Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement

Published:2024-05 Issue:5 Volume:49 Page:102524
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Alsereidi Fatmah R.,Khashim Zenith,Marzook Hezlin,Gupta Anamika,Al-Rawi Ahmed M.,Ramadan Mahmoud M.,Saleh Mohamed A.^ORCID

Publisher

Elsevier BV

Reference101 articles.

1. Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review;Lopaschuk;JACC Basic Transl Sci,2020

2. Effects of SGLT2 inhibitors on kidney and cardiovascular function;Vallon;Annu Rev Physiol,2021

3. SGLT2 inhibitors and cardiovascular risk: lessons learned from the EMPA-REG OUTCOME study;Abdul-Ghani;Diabetes Care,2016

4. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin cardiovascular assessment study);Mahaffey;Circulation,2018

5. Canagliflozin and cardiovascular disease- results of the CANVAS trial;Shah;J Commun Hosp Intern Med Perspect,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress granules in atherosclerosis: Insights and therapeutic opportunities;Current Problems in Cardiology;2024-10

2. The role of NF-κB in diabetic cardiomyopathy;All Life;2024-09-05

3. Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular Diseases;ACS Medicinal Chemistry Letters;2024-07-11

4. Endothelial Protection by Sodium-Glucose Cotransporter 2 Inhibitors: A Literature Review of In Vitro and In Vivo Studies;International Journal of Molecular Sciences;2024-07-02

5. A review regarding the article ‘Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement’;Current Problems in Cardiology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3